Greetings

Kyongbo Pharmaceutical reaches out
to you with love and affection.
Thank you for visiting our website.

Germany rose from the ashes of World War II to become a wealthy and powerful modern nation not because it had access to abundant resources, but because it had a highly advanced fine chemistry sector.
The fine chemistry sector is a source of immense added value and a sector we need to foster and nurture in the 21st century if we are to elevate our nation’s status to that of an advanced one.

Manufacturing of active pharmaceutical ingredients, in particular, is a fine chemistry industry requiring endless research and constant advancements in technology and simultaneously promises a huge potential for future growth and value.
This is why the mission of Kyongbo Pharmaceutical, a specialist in the manufacture of active pharmaceutical ingredients, is so incredibly important.

Here at Kyongbo Pharmaceutical, each and every one of us is dedicated to researching and developing innovative technologies that will enable us to deliver products of the highest quality possible in the quickest timeframe possible in order to survive and thrive in today’s open and globalized market environment.

Two of our first tasks following the founding of the company were to establish a central research center and to institute a system for selective adoption of advanced technologies from abroad. We have since then been making concerted and enterprise-wide efforts to develop new technologies and products of great economic value.

Efficient manufacturing of active pharmaceutical ingredients through the use of biotechnology, the very future of fine chemistry, is also a key pursuit of Kyongbo Pharmaceutical.

Kyongbo Pharmaceutical contributes to national health promotion, through providing with active pharmaceutical ingredients as well as finished products.
As a leader in the manufacturing of pharmaceutical ingredients and a pioneer in fine chemistry, Kyongbo Pharmaceutical pledges to continue to grow as a corporation of the people and the world and to remain committed to improving the health and the welfare of humankind and to protecting the environment.

CEO Tae Young KimCEO Tae Young Kim

의약품 회수에 관한 공표

(의약품, 3등급 위해성)


약사법 제72조의 규정에 의하여 아래의 의약품 등을 긴급 회수함을 공표합니다

 



. 회수제품명: 스키다제정(스트렙토키나제·스트렙토도르나제)(포장단위: 500/)


. 제조일자: 2022.06.11 ~ 2022.06.12까지 생산한 제품


. 제조번호: BC004, BC005


. 회수사유: 임상재평가 결과 유효성 미입증


. 회수방법: 취급 판매업소 및 의료기관별 방문하여 도매업소 교환 수거


. 회수영업자: ㈜경보제약 (대표자 김태영)


. 영업자주소: 충청남도 아산시 실옥로 174


. 연락처: TEL) 02-365-2312, FAX) 02-2175-2395


자. 자료작성년월일: 2023. 12. 06.

 


 당해 회수대상 의약품 등을 보관하고 있는 판매업소 및 약국이나 의료기관에서는 

   즉시 판매를 중지하고 회수영업자에게 반품하여 주시기 바랍니다.

X

위해 의약품등 회수에 관한 공표

(의약품, 2등급 위해성)


약사법 제72조의 규정에 의하여 아래의 의약품 등을 긴급 회수함을 공표합니다


 

. 회수제품명자누스틴듀오정10/100밀리그램(다파글리플로진, 시타글립틴)

                     (포장단위: 28 정/상자(7정/Alu-Alu x 4))


. 제조일자 / 유효기간 : 2023.06.29 / 2025.06.28


. 제조번호: CC001


. 회수사유불순물(NTTP) 초과 검출 우려에 따른 사전 예방적 조치로 시중 유통품에 대해 영업자 회수


. 회수방법: 공급받은 업체를 통하여 반품


. 회수의무자: ㈜경보제약 (대표자 김태영)


. 의무자주소: 충청남도 아산시 실옥로 174


. 연락처: TEL) 02-365-2312, FAX) 02-2175-2395


: 자료작성년월일: 2024. 02. 19.

 

 당해 회수대상 의약품 등을 보관하고 있는 판매업소 및 약국이나 의료기관에서는 즉시 판매를 중지하고 회수영업자에게 반품하여 주시기 바랍니다.

X